Literature DB >> 190846

Fine structure of myomedulloblastoma.

R Stahlberger, R L Friede.   

Abstract

Electronmicroscopic studies in a case of myomedulloblastoma support the concept that the medulloblastoma and the myoblastoma component of the tumor derive drom different cell lines. The myoblastoma component shows bundles of myogenic elements, whereby quite undifferentiated cells lacking myofilaments are tightly attached to differentiated elements having well organized myofilaments. These bundles are encompassed by a common basement membrane, and their cells are joined by junctions, helping the identification of the undifferentiated elements. No comparable structures were seen in the medulloblastoma component. The fine structure of the myoblastoma is reminiscent of aspects of normal fetal development of skeletal muscle.

Entities:  

Mesh:

Year:  1977        PMID: 190846     DOI: 10.1007/bf00684539

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  [A MEDULLOBLASTOMA WITH TRANSVERSELY STRIATED MUSCLE FIBERS].

Authors:  J W BOELLAARD
Journal:  Arch Psychiatr Nervenkr       Date:  1964-11-19

2.  Human brain tumors: an electron-microscopic study.

Authors:  A J RAIMONDI; S MULLAN; J P EVANS
Journal:  J Neurosurg       Date:  1962-09       Impact factor: 5.115

3.  Myogenesis and neurogenesis in the chick embryo: A comparative study.

Authors:  Stanley E Read; Misau Takeda; William H Kirkaldy-Willis
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1971-09

4.  Population of muscle satellite cells in relation to age and mitotic activity.

Authors:  D B Allbrook; M F Han; A E Hellmuth
Journal:  Pathology       Date:  1971-07       Impact factor: 5.306

5.  On finding striated muscle in the brain.

Authors:  S F Hoffman; L B Rorke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-12       Impact factor: 10.154

6.  Medulloblastoma with cross-striated muscle. A fine structural study.

Authors:  K Misugi; L Liss
Journal:  Cancer       Date:  1970-06       Impact factor: 6.860

7.  The ultrastructure of medulloblastomas.

Authors:  F Matakas; J Cervós-Navarro; F Gullotta
Journal:  Acta Neuropathol       Date:  1970       Impact factor: 17.088

8.  The ultrastructure of medulloblastoma in tissue culture.

Authors:  F Gullotta; G Kersting
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

9.  Electron microscopy of neuronal and glial differentiation in the developing brain of the chick.

Authors:  W Wechsler; K Meller
Journal:  Prog Brain Res       Date:  1967       Impact factor: 2.453

10.  Cystic teratomas and teratoid tumors of the central nervous system in infancy and childhood.

Authors:  F D INGRAHAM; O T BAILEY
Journal:  J Neurosurg       Date:  1946-11       Impact factor: 5.115

View more
  6 in total

1.  Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component.

Authors:  T Höll; P Kleihues; M G Yasargil; O D Wiestler
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Ultrastructural study of medullomyoblastoma.

Authors:  G F Walter; J M Brucher
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

3.  Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation.

Authors:  William Rattenberry; Colleen H McDonough; Peter C Burger; Kenneth J Cohen
Journal:  J Neurooncol       Date:  2011-06-19       Impact factor: 4.130

4.  Ultrastructural aspects of myogenesis found in neoplasms.

Authors:  F P Prince
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

5.  Medullomyoblastoma: report of two cases.

Authors:  D Schiffer; M T Giordana; S Pezzotta; T Pezzulo; M C Vigliani
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

6.  Striated muscle cells in the leptomeninges in cerebral dysplasia.

Authors:  M W Ambler
Journal:  Acta Neuropathol       Date:  1977-11-28       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.